A mouse bleeding model to study oral anticoagulants.

about

Anticoagulation increases alveolar hemorrhage in mice infected with influenza A.Involvement of the heparanase procoagulant domain in bleeding and wound healing.Clot stability as a determinant of effective factor VIII replacement in hemophilia A.

P2860

Q40399798-A0269A67-F695-4379-8C14-00B01A8E1603 Q50703286-0327BC36-76FF-4A5D-9796-06BBF360C543 Q53068802-D84F7903-48D6-49F8-B832-5E4AF58A8313

P2860

A mouse bleeding model to study oral anticoagulants.

Item

http://www.wikidata.org/entity/Q39372785

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

A mouse bleeding model to study oral anticoagulants.

@en

A mouse bleeding model to study oral anticoagulants.

@nl

type

Item

label

A mouse bleeding model to study oral anticoagulants.

@en

A mouse bleeding model to study oral anticoagulants.

@nl

prefLabel

A mouse bleeding model to study oral anticoagulants.

@en

A mouse bleeding model to study oral anticoagulants.

@nl

P1476

A mouse bleeding model to study oral anticoagulants

@en

P2093

Dougald M Monroe

http://www.w3.org/2001/XMLSchema#string

Maureane Hoffman

http://www.w3.org/2001/XMLSchema#string

P2860

A specific antidote for dabigatran: functional and structural characterization

Dabigatran versus warfarin in patients with atrial fibrillation

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment.

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis

New anticoagulants: A concise review.

Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate.

A sensitive venous bleeding model in haemophilia A mice: effects of two recombinant FVIII products (N8 and Advate(®)).

P304

S6-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.THROMRES.2014.03.003

http://www.w3.org/2001/XMLSchema#string

P478

133 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Dougald M. Monroe

Maureane Hoffman

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261837306

http://www.w3.org/2001/XMLSchema#string

P698

24759147

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

4014069

http://www.w3.org/2001/XMLSchema#string

A mouse bleeding model to study oral anticoagulants.

about

P2860

P2860

A mouse bleeding model to study oral anticoagulants.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932